SOSV

PluriCell wants to positively impact the lives of millions of patients suffering from chronic heart failure condition by injecting healthy bona fide lab-made human heart cells in their failing heart, improve its function and, ultimately, the clinical outcome of the patients. Our tech enables us not only tackle heart diseases, but potentially, many chronic disorders currenly untractable.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Inflammatory disease affects us all. We looked 300 million years into our past to imagine a healthier future, beyond the limitations of today’s anti-inflammatory drugs. Lupa Bio is developing an entirely new class of safer, anti-inflammatory therapeutics based on compounds found in mothers’ milk ...because no technology today can screen like the forces of nature. ​

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

We are a platform of insect-based biotechnology integrating biology with engineering and molecular sciences to accelerate the building with biology. We are capitalizing on our experience with vertically farmed Black Soldier Fly to use the insect as a mini-biofactory reducing the capital and operational costs of conventional bioreactors.

We are a platform of insect-based biotechnology integrating biology with engineering and molecular sciences to accelerate the building with biology. We are capitalizing on our experience with vertically farmed Black Soldier Fly to use the insect as a mini-biofactory reducing the capital and operational costs of conventional bioreactors.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms to create innovative plant-inspired proteins, such as brazzein, for applications in the food and beverage industries. Additionally, Magellan Life Sciences offers the XSeed platform, which leverages synthetic biology to advance the development of novel proteins aimed at enhancing the food, health, and nutrition sectors.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Inflammatory disease affects us all. We looked 300 million years into our past to imagine a healthier future, beyond the limitations of today’s anti-inflammatory drugs. Lupa Bio is developing an entirely new class of safer, anti-inflammatory therapeutics based on compounds found in mothers’ milk ...because no technology today can screen like the forces of nature. ​

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

LIVIN farms is a technology company in the alternative protein sector. It empowers everyone to start a food revolution out of their kitchen.

Sothic Bioscience Ltd. operates as a biotech company in Ireland. The company develops LimuleX, a bio-production platform to make bio-identical replacement for naturally sourced limulus amebocyte lysate, as well as to remove the threatened horseshoe crab species from the pharmaceutical quality control supply chain. Sothic Bioscience Ltd. was founded in 2015 and is based in Cork, Ireland.

Inflammatory disease affects us all. We looked 300 million years into our past to imagine a healthier future, beyond the limitations of today’s anti-inflammatory drugs. Lupa Bio is developing an entirely new class of safer, anti-inflammatory therapeutics based on compounds found in mothers’ milk ...because no technology today can screen like the forces of nature. ​

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

CorNatural develops bio-based sustainable products to offer a range of natural products. The company aims to upcycle waste streams into value-added products, using pioneering synthetic biology and genetic engineering techniques. CorNatural was founded in 2019 and is headquartered in London.

Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

LIVIN farms is a technology company in the alternative protein sector. It empowers everyone to start a food revolution out of their kitchen.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

11 Biomics LLC develops biological therapeutics for the cannabis industry. It offers small and large scale treatment and protection against fungal and bacterial diseases in cannabis and hemp. The company is based in Albuquerque, New Mexico.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

We are made up of a diverse range of cell types that can mutate or go awry, testing these cells to develop new therapies, to understand diseases or for biopsies is incredibly time-consuming. Cellari enables doctors and non-specialists to take full advantage of recent developments in artificial intelligence. Cellari are providing the most precise “active learning model” for bioimage segmentation combined with an intuitive and easy-to-use user interface for carrying out complex bioimaging tasks. An automated statistical testing service ensures statistical validity of clinical and research related results along with unparalleled review and methodology transparency functionalities.

Biomathematica is a biotech start-up providing a high level modeling service to characterize and understand a biological process, simulate, monitor, control, optimize and modify its behavior. Biomathematica has developed innovative genome-scale metabolic models to answer your questions and improve your business: from genome to microbiome, from genome to cell interactions.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms to create innovative plant-inspired proteins, such as brazzein, for applications in the food and beverage industries. Additionally, Magellan Life Sciences offers the XSeed platform, which leverages synthetic biology to advance the development of novel proteins aimed at enhancing the food, health, and nutrition sectors.

Cell-Free Technology Limited specializes in the production of cell-free extracts that enable the synthesis of essential biomolecules, including insulin, various scents, biocompatible color palettes, and fluorescent proteins. Founded in 2017 and headquartered in Cork, Ireland, the company offers ultra-low-cost cell-free extracts and kits designed to facilitate biological processes outside of traditional laboratory settings. This innovative approach allows for the expression of DNA without the constraints of biological or GMO regulations, making it possible to conduct biological experiments in diverse environments. Cell-Free Technology is committed to open-source projects, promoting knowledge sharing and collaboration within the scientific community.

Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

Scaled Biolabs Inc., founded in 2016 and based in San Francisco, California, specializes in biotech research and development solutions focused on cell-based medicines. The company has developed a Cell Therapy Discovery Engine that leverages microfluidics, automation, and machine learning to optimize the discovery and manufacturing of cell therapies. This innovative platform allows biotech and pharmaceutical companies to evaluate numerous parameters across extensive experimental processes, enhancing understanding of cell-driven biology. By streamlining the development of novel cell-based products, Scaled Biolabs aims to reduce time to market and improve clinical outcomes. In addition to its collaborative efforts, the company also advances its own cell therapy programs, including a CIRM-funded initiative targeting iPSC-derived dopaminergic neurons for treating Parkinson’s disease.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Galactica Biotech Limited, founded in 2017 and based in Cork, Ireland, specializes in developing artificial intelligence-based solutions for drug design, machine learning, and systems biology. The company focuses on drug repurposing, utilizing its technology to identify new applications for existing molecules in both market and development phases. This innovative approach aims to discover treatments for major and orphan diseases, thereby reducing risks for patients and minimizing time and costs for pharmaceutical companies.

Cell-Free Technology Limited specializes in the production of cell-free extracts that enable the synthesis of essential biomolecules, including insulin, various scents, biocompatible color palettes, and fluorescent proteins. Founded in 2017 and headquartered in Cork, Ireland, the company offers ultra-low-cost cell-free extracts and kits designed to facilitate biological processes outside of traditional laboratory settings. This innovative approach allows for the expression of DNA without the constraints of biological or GMO regulations, making it possible to conduct biological experiments in diverse environments. Cell-Free Technology is committed to open-source projects, promoting knowledge sharing and collaboration within the scientific community.

SwaLife Biotech Limited is a biotechnology company based in Cork, Ireland, founded in 2017. The company focuses on discovering and synthesizing medicinal compounds, particularly novel anticancer plant alkaloids. SwaLife Biotech specializes in extracting small molecules from plants to develop products aimed at medical and cosmetic applications. Its research targets the inhibition of proteins or enzymes involved in DNA damage response, which is significant in the context of skin and breast cancer. The company's offerings include an anti-cancer drug, a cosmetic product for sun UV protection, and treatments for rare diseases.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

Scaled Biolabs Inc., founded in 2016 and based in San Francisco, California, specializes in biotech research and development solutions focused on cell-based medicines. The company has developed a Cell Therapy Discovery Engine that leverages microfluidics, automation, and machine learning to optimize the discovery and manufacturing of cell therapies. This innovative platform allows biotech and pharmaceutical companies to evaluate numerous parameters across extensive experimental processes, enhancing understanding of cell-driven biology. By streamlining the development of novel cell-based products, Scaled Biolabs aims to reduce time to market and improve clinical outcomes. In addition to its collaborative efforts, the company also advances its own cell therapy programs, including a CIRM-funded initiative targeting iPSC-derived dopaminergic neurons for treating Parkinson’s disease.

Scaled Biolabs Inc., founded in 2016 and based in San Francisco, California, specializes in biotech research and development solutions focused on cell-based medicines. The company has developed a Cell Therapy Discovery Engine that leverages microfluidics, automation, and machine learning to optimize the discovery and manufacturing of cell therapies. This innovative platform allows biotech and pharmaceutical companies to evaluate numerous parameters across extensive experimental processes, enhancing understanding of cell-driven biology. By streamlining the development of novel cell-based products, Scaled Biolabs aims to reduce time to market and improve clinical outcomes. In addition to its collaborative efforts, the company also advances its own cell therapy programs, including a CIRM-funded initiative targeting iPSC-derived dopaminergic neurons for treating Parkinson’s disease.

Unibiome develops fermentative microbes that produces vitamins and other healthy compounds and designed to be used with any fermentation-based food to increase its nutritional value. The company was founded in 2016 and is based in Paris, France.

Sothic Bioscience Ltd. operates as a biotech company in Ireland. The company develops LimuleX, a bio-production platform to make bio-identical replacement for naturally sourced limulus amebocyte lysate, as well as to remove the threatened horseshoe crab species from the pharmaceutical quality control supply chain. Sothic Bioscience Ltd. was founded in 2015 and is based in Cork, Ireland.

Cell Reserves Inc. manufactures protein and peptide-based therapeutics for the treatment of diseases. It manufactures bio-pharmaceuticals using molecular shields that increase the bio-availability of therapeutics in circulation. Cell Reserves Inc. is based in Ottawa, Canada.

Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

LIVIN farms is a technology company in the alternative protein sector. It empowers everyone to start a food revolution out of their kitchen.

Sothic Bioscience Ltd. operates as a biotech company in Ireland. The company develops LimuleX, a bio-production platform to make bio-identical replacement for naturally sourced limulus amebocyte lysate, as well as to remove the threatened horseshoe crab species from the pharmaceutical quality control supply chain. Sothic Bioscience Ltd. was founded in 2015 and is based in Cork, Ireland.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Affinity focuses on reducing the manufacturing costs of biologics and providing a consulting service on the scientific needs of our customers. Our services offer customers a single resource for the manufacturing of their products.

They are building a flexible and friendly robotic lab assistant to help scientists be scientists. They’re aBioBot, and we’re here to usher in an ergonomic laboratory and unleash a revolution.

Affinity focuses on reducing the manufacturing costs of biologics and providing a consulting service on the scientific needs of our customers. Our services offer customers a single resource for the manufacturing of their products.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Benthic Labs is a synthetic biology company focusing on the synthesis of a new biopolymer using natural filaments. Their project involves the production of a new polymer using filaments made naturally by the Hagfish. These filaments are 100x thinner than a human hair and stronger than nylon, steel and even Kevlar. As the hagfish cannot be farmed economically, they propose synthesising the filament using bacteria to create a new biological material. This material will be lightweight, strong and as it is natural, will be completely biodegradable. What will their new biopolymer be used for? With demand for such a product in the military, medical and automobile sectors, the possibilities are endless!

SocialSci operates an online platform that allows to conduct scientific process surveys and in lab studies by academic researchers. Its platform allows users to find studies in their local area that are looking for live participants, as well as to port their scientific research onto the online space. The company’s platform is used by colleges and universities in the United States. SocialSci was founded in 2009 and is based in Cambridge, Massachusetts.